Zaquborjeong 20 mg (Zastaprazan Citrate)

Adult dose

This medicine is administered to adults as follows. It may be taken with or without food. 1. Treatment of erosive gastroesophageal reflux disease - Administer 20 mg orally once daily for 4 weeks. If the condition is not resolved, continue treatment for an additional 4 weeks. 2. Treatment of gastric ulcers - Administer 20 mg orally once daily for up to 8 weeks.

This medication should not be administered to certain patients. Patients who have had allergic reactions to this medication or its components, as well as those taking medications containing atazanavir, nelpfinavir, or rilpivirine, should not use this medication. Pregnant or breastfeeding women should also not take this medication. Additionally, this medication contains lactose, so patients with genetic issues like lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. Patients with impaired liver or kidney function should use this medication with caution, and seniors also need to be careful. Various side effects can occur while taking this medication, including gastrointestinal disturbances, neurological abnormalities, skin rashes, musculoskeletal pain, so any unusual symptoms should be discussed with healthcare providers immediately. This medication suppresses gastric acid, which may increase the risk of bacterial infections due to reduced acidity in the stomach. Particularly in hospitalized patients, caution should be exercised to prevent Clostridium difficile infection, and if diarrhea persists, healthcare providers should be informed. Long-term use may increase the risk of osteoporosis-related fractures, so regular bone density checks and preventative measures should be considered if necessary. Moreover, long-term use for more than three months may lead to hypomagnesemia, necessitating periodic checks of magnesium levels and supplementation when needed. Long-term use of this medication may result in vitamin B12 deficiency, so appropriate testing should be conducted if related symptoms arise. The effects of this medication on driving or operating machinery are unclear, but caution is warranted depending on the patient’s condition. This medication may interact with other drugs, so it's essential to inform healthcare providers about other medications being taken, especially when combined with certain antiviral or antibiotic drugs. Pregnant or breastfeeding women should not use this medication and should discontinue breastfeeding if taking it. The safety and efficacy in children and adolescents have not been adequately confirmed, so use should be avoided. There have been no reported special poisoning symptoms due to overdose, but observation of symptoms and general treatment should be sought if needed. This medication should be kept out of reach of children and it is safer and better for quality maintenance not to transfer it to another container.

• hernia
• dyspepsia
• chronic gastritis
• erosive gastritis
• nausea
• abdominal bloating
• diarrhea
• duodenal polyps
• discomfort in the upper abdomen
• bloating

This medication should be stored in a sealed container to protect it from air and moisture, ideally at room temperature between 1°C and 30°C.

Appearance

Pink round film-coated tablet

Package unit

28 tablets/bottle, 7 tablets/bottle, 300 tablets/bottle